Work

Novel metric for evaluating pre-exposure prophylaxis programme effectiveness in real-world settings

Year: 2020

Type: article

Source: The Lancet HIV

Authors: Cheryl Hendrickson, Lawrence Long, David van de Vijver, Charles Boucher, Heidi O'Bra, Cassidy W Claassen, Mwansa Njelesani, Crispin Moyo, Daliso B Mumba, Hasina Subedar, Lloyd Mulenga, Sydney Rosen, Brooke E Nichols

Institutions: University of the Witwatersrand, Boston University, Erasmus MC, United States Agency for International Development, Right to Care, National HIV/AIDS/STI/TB Council, Department of Health, Ministry of Health

Language: English

Topic: HIV/AIDS Research and Interventions

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: United States Agency for International Development, Gilead Sciences, Meso Scale Diagnostics, National Institutes of Health, National Institute of Mental Health, Fogarty International Center

Awards: G1857082937, EVIDENCE IS A PROGRAM OF APPLIED RESEARCH AND EVALUATION, INCLUDING COST AND COST EFFECTIVENESS ANALYSIS, COST MODELING, AND EPIDEMIOLOGICAL ANALYSIS, AIMED AT ASSISTING THE GOVERNMENT OF SOUTH AFRICA TO ACHIEVE THE GOALS OF ITS NATIONAL STRATEGIC PLAN ON HIV, TB AND STIS 2017-2022, NATIONAL AND INTERNATIONAL 90-90-90 TARGETS, AND PEPFAR OBJECTIVES., ANTIRETROVIRAL THERAPY SIMPLIFICATION OPTIMIZATION OF PROGRAMS AND SERVICES (ART-OPS), G9000079616

OpenAlex ID: W3003553872

FWCI: 0.367

Cites: 9

Cited by: 15

Related to: 10